We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

48 hedge funds and large institutions have $56.7M invested in abrdn Life Sciences Investors in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

9% more funds holding

Funds holding: 44 → 48 (+4)

1.09% more ownership

Funds ownership: 11.91% → 13.01% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less capital invested

Capital invested by funds: $65M → $56.7M (-$8.29M)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
19
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DA
Doliver Advisors
Texas
+$1.36M
2
Morgan Stanley
Morgan Stanley
New York
+$1.01M
3
LTFS
Ladenburg Thalmann Financial Services
Florida
+$901K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$835K
5
Citigroup
Citigroup
New York
+$770K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$585K
2
LPL Financial
LPL Financial
California
-$400K
3
Baird Financial Group
Baird Financial Group
Wisconsin
-$375K
4
AAM
Advisors Asset Management
Colorado
-$345K
5
CL
CSS LLC
Illinois
-$307K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$295K +$97.7K +3,489 +36%
RJFSA
27
Raymond James Financial Services Advisors
Florida
$289K +$360K +12,857 New
MIC
28
Meridian Investment Counsel
California
$275K – – –
WS
29
Wedbush Securities
California
$235K -$16.5K -589 -5%
CCP
30
Clough Capital Partners
Massachusetts
$200K +$249K +8,900 New
Creative Planning
31
Creative Planning
Kansas
$118K +$146K +5,223 New
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$109K – – –
VNA
33
Valley National Advisers
Pennsylvania
$73K +$420 +15 +0.5%
GT
34
Glenmede Trust
Pennsylvania
$45K +$57.1K +2,038 New
US Bancorp
35
US Bancorp
Minnesota
$38K +$46.8K +1,672 New
CFN
36
Cordasco Financial Network
Florida
$32K +$728 +26 +2%
SF
37
Synovus Financial
Georgia
$24K +$9.69K +346 +48%
SIA
38
SeaBridge Investment Advisors
New Jersey
$22K – – –
MFS
39
MSI Financial Services
Massachusetts
$22K +$504 +18 +2%
NFG
40
Next Financial Group
Texas
$19K +$504 +18 +2%
MSFP
41
Mark Sheptoff Financial Planning
Connecticut
$10K – – –
ASN
42
Advisory Services Network
Georgia
$1K – – –
TFA
43
Transamerica Financial Advisors
Florida
$1K – – –
TJHA
44
Thomas J. Herzfeld Advisors
Florida
$1K +$1.68K +60 New
Baird Financial Group
45
Baird Financial Group
Wisconsin
– -$375K -13,287 Closed
CL
46
CSS LLC
Illinois
– -$307K -10,897 Closed
CAL
47
Capital Analysts LLC
Pennsylvania
– -$113K -4,000 Closed
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
– -$76K -2,700 Closed
FWM
49
Focused Wealth Management
New York
– -$20.8K -744 -99%
HCMT
50
Highland Capital Management (Texas)
Texas
– -$11K -391 Closed
1
2
3

HQL Hedge Fund Activity: Q3 2015 in Review

48 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2015, worth a combined $56.7M — down 13% from $65M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new HQL positions and 5 closed out — a net gain of 4 holders — while 19 added to existing stakes and 12 trimmed.

The largest buyer was Doliver Advisors, opening a new position worth an estimated $1.36M. The largest seller was UBS Group, cutting an estimated $585K.

  • 48 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2015, up from 44 in Q2 2015.
  • Funds reported $56.7M of abrdn Life Sciences Investors stock for Q3 2015, down 13% quarter-over-quarter.
  • 9 funds opened new abrdn Life Sciences Investors positions in Q3 2015 and 5 closed out, a net change of +4 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2015 was Doliver Advisors, an estimated $1.36M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2015 was UBS Group, an estimated $585K sold.

Based on aggregated 13F filings for Q3 2015.